Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1432597c4e83d4ec79685539afb3f1d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-3809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26 |
filingDate |
2015-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa175b24676834425cdbfe4e1c8dcf00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dadc796980e4fe47032cd1a78871ca7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db40234e6e1b1bca57fb449a6de2129b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12be4043908a971822aacc9518e67777 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd8f4cd9e505fbd74ea10fb0889d5613 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10bb37f85c5c1c29d577459e8661cbe1 |
publicationDate |
2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-112979818-A |
titleOfInvention |
Binding partners specific for vitamin D epimers |
abstract |
Antibodies are raised against compounds of formula (I) wherein Z is an immunogenic carrier. These antibodies are capable of specifically binding to the corresponding antibodies. The antibodies are specific for epimers of vitamin D. Antibodies according to the principles described herein may be used to minimize or eliminate 3-epimer cross-reactivity in assays for non-epimeric forms of vitamin D analytes. Use of immunogens directed against compounds of formula (I) wherein Z is an immunogenic carrierThe prepared antibodies as blocking agents can substantially avoid over-estimation of total non-epimeric vitamin D analytes caused by cross-reactivity of 3-epimeric vitamin D with antibodies to vitamin D analytes. |
priorityDate |
2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |